• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clinical characteristics of individuals with Down syndrome deceased with CoVID‐19 in Italy—A case series

Emily

Editor, Senior Moderator
https://onlinelibrary.wiley.com/doi/full/10.1002/ajmg.a.61867
Clinical characteristics of individuals with Down syndrome deceased with CoVID‐19 in Italy—A case series

Emanuele Rocco Villani
Angelo Carf?
Antonella Di Paola
Luigi Palmieri
Chiara Donfrancesco
Cinzia Lo Noce
Domenica Taruscio
Paola Meli
… See all authors

First published: 12 September 2020
https://doi.org/10.1002/ajmg.a.61867

...
CONCLUSIONS

Individuals with DS deceased with CoVID‐19 are younger than individuals without DS. Comorbidity burden and increased risk of complications (i.e., bacterial superinfections) can influence CoVID‐19 prognosis in individuals with DS. Specific strategies to prevent and mitigate the effects of CoVID‐19 in the population with DS are needed.
 
Back
Top Bottom